273 related articles for article (PubMed ID: 26882501)
1. Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.
Repass J; Maherali N; Owen K; ;
Elife; 2016 Feb; 5():. PubMed ID: 26882501
[TBL] [Abstract][Full Text] [Related]
2. Replication Study:
Repass J;
Elife; 2018 Mar; 7():. PubMed ID: 29533182
[TBL] [Abstract][Full Text] [Related]
3. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients.
Li YY; Ge QX; Cao J; Zhou YJ; Du YL; Shen B; Wan YJ; Nie YQ
World J Gastroenterol; 2016 Mar; 22(11):3227-33. PubMed ID: 27004000
[TBL] [Abstract][Full Text] [Related]
4. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population.
Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270
[TBL] [Abstract][Full Text] [Related]
5. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
[TBL] [Abstract][Full Text] [Related]
6. Registered report: Diverse somatic mutation patterns and pathway alterations in human cancers.
Sharma V; Young L; Allison AB; Owen K; ;
Elife; 2016 Feb; 5():. PubMed ID: 26894955
[TBL] [Abstract][Full Text] [Related]
7. Registered report: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.
Khan I; Kerwin J; Owen K; Griner E; ;
Elife; 2015 Sep; 4():. PubMed ID: 26335297
[TBL] [Abstract][Full Text] [Related]
8. Fusobacterium nucleatum in biopsied tissues from colorectal cancer patients and alcohol consumption in Korea.
Kim M; Lee ST; Choi S; Lee H; Kwon SS; Byun JH; Kim YA; Rhee KJ; Choi JR; Kim TI; Lee K
Sci Rep; 2020 Nov; 10(1):19915. PubMed ID: 33199749
[TBL] [Abstract][Full Text] [Related]
9. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
[TBL] [Abstract][Full Text] [Related]
10. Registered report: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
Bhargava A; Pelech S; Woodard B; Kerwin J; Maherali N; ;
Elife; 2016 Feb; 5():. PubMed ID: 26882073
[TBL] [Abstract][Full Text] [Related]
11. Registered report: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment.
Evans J; Essex A; Xin H; Amitai N; Brinton L; Griner E; ;
Elife; 2015 Aug; 4():. PubMed ID: 26287525
[TBL] [Abstract][Full Text] [Related]
12. Registered report: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.
Lesnik J; Antes T; Kim J; Griner E; Pedro L; ;
Elife; 2016 Jan; 5():e07383. PubMed ID: 26826285
[TBL] [Abstract][Full Text] [Related]
13. Registered report: Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF.
Bhargava A; Anant M; Mack H; ;
Elife; 2016 Feb; 5():. PubMed ID: 26885666
[TBL] [Abstract][Full Text] [Related]
14.
Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
[TBL] [Abstract][Full Text] [Related]
15. Registered report: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia.
Fung JJ; Kosaka A; Shan X; Danet-Desnoyers G; Gormally M; Owen K; ;
Elife; 2015 Sep; 4():. PubMed ID: 26327698
[TBL] [Abstract][Full Text] [Related]
16. Registered report: Systematic identification of genomic markers of drug sensitivity in cancer cells.
Vanden Heuvel JP; Bullenkamp J;
Elife; 2016 Jun; 5():. PubMed ID: 27336789
[TBL] [Abstract][Full Text] [Related]
17. Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients.
Kunzmann AT; Proença MA; Jordao HW; Jiraskova K; Schneiderova M; Levy M; Liska V; Buchler T; Vodickova L; Vymetalkova V; Silva AE; Vodicka P; Hughes DJ
Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1891-1899. PubMed ID: 31367996
[TBL] [Abstract][Full Text] [Related]
18. High occurrence of Fusobacterium nucleatum and Clostridium difficile in the intestinal microbiota of colorectal carcinoma patients.
Fukugaiti MH; Ignacio A; Fernandes MR; Ribeiro Júnior U; Nakano V; Avila-Campos MJ
Braz J Microbiol; 2015; 46(4):1135-40. PubMed ID: 26691472
[TBL] [Abstract][Full Text] [Related]
19. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
[TBL] [Abstract][Full Text] [Related]
20. Alteration of microRNA-4474/4717 expression and CREB-binding protein in human colorectal cancer tissues infected with Fusobacterium nucleatum.
Feng YY; Zeng DZ; Tong YN; Lu XX; Dun GD; Tang B; Zhang ZJ; Ye XL; Li Q; Xie JP; Mao XH
PLoS One; 2019; 14(4):e0215088. PubMed ID: 30951563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
